OssDsign - On the right track, but estimate changes called for
2021-12-02 10:20:00
Redeye revisits its estimates for OssDsign in the coming years following the Q3 report, which continued to show progression, though sales were somewhat below our expectations. While we see an attractive growth case ahead and a significant upside potential to or Base Case, we downward adjust our sales projections and valuation slightly.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/